Araclon Biotech
Pre-clinicalAraclon Biotech, a subsidiary of Grifols, is a company specializing in the research and development of methods for the early diagnosis and preventive treatment of Alzheimer’s Disease.
Founded
2004
Focus
DiagnosticsVaccines
About
Araclon Biotech, a subsidiary of Grifols, is a company specializing in the research and development of methods for the early diagnosis and preventive treatment of Alzheimer’s Disease.
Funding History
2Total raised: $17.5M
Series A$15MSabadell Venture CapitalNov 15, 2021
Grant$2.5MEuropean UnionJun 15, 2019
Company Info
TypePrivate
Founded2004
LocationZaragoza, Spain
StagePre-clinical
Contact
SIMILAR COMPANIES
A4Cell
Pre-clinical · Barcelona
Ability Pharma
Phase 2 · Barcelona
Abyntek Biopharma
Pre-clinical · Derio
Acellera
Pre-clinical · Barcelona
BeCytes Biotechnologies
Pre-clinical · Barcelona
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile